{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T10:26:15Z","timestamp":1781259975876,"version":"3.54.1"},"reference-count":33,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,11,1]]},"DOI":"10.2169\/internalmedicine.4912-20","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T22:06:06Z","timestamp":1594073166000},"page":"2751-2756","source":"Crossref","is-referenced-by-count":3,"title":["Acquired Gray Platelet Syndrome Associated with Primary Myelofibrosis"],"prefix":"10.2169","volume":"59","author":[{"given":"Kentaro","family":"Ido","sequence":"first","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Nakane","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Tanizawa","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Makuuchi","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Okamura","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Koh","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Nanno","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsutaka","family":"Nishimoto","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asao","family":"Hirose","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Nakamae","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Koh","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Hino","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Nakamae","sequence":"additional","affiliation":[{"name":"Hematology, Graduate School of Medicine, Osaka City University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Tefferi A. Primary myelofibrosis: 2019 update on diagnosis, risk-stratification and management. Am J Hematol 93: 1551-1560, 2018."},{"key":"2","unstructured":"2. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. Swerdlow SH, Campo E, Harris NL, et al., Eds. Myeloproliferative neoplasms. Lyon, 2017: 29-60."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Martin K. Risk factors for and management of MPN-associated bleeding and thrombosis. Curr Hematol Malig Rep 12: 389-396, 2017.","DOI":"10.1007\/s11899-017-0400-3"},{"key":"4","unstructured":"4. Kc D, Falchi L, Verstovsek S. The underappreciated risk of thrombosis and bleeding in patients with myelofibrosis: a review. Ann Hematol 96: 1595-1604, 2017."},{"key":"5","unstructured":"5. Appelmann I, Kreher S, Parmentier S, et al. Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH). Ann Hematol 95: 707-718, 2016."},{"key":"6","unstructured":"6. Kander EM, Raza S, Zhou Z, et al. Bleeding complications in BCR-ABL negative myeloproliferative neoplasms: prevalence, type, and risk factors in a single-center cohort. Int J Hematol 102: 587-593, 2015."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Avram S, Lupu A, Angelescu S, Olteanu N, Mut-Popescu D. Abnormalities of platelet aggregation in chronic myeloprolioferative disorders. J Cell Mol Med 5: 79-87, 2001.","DOI":"10.1111\/j.1582-4934.2001.tb00140.x"},{"key":"8","unstructured":"8. Takenaka K, Shimoda K, Uchida N, et al. Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan. Int J Hematol 105: 59-69, 2017."},{"key":"9","unstructured":"9. Gangat N, Caramazza D, Vaidya R, et al. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status. J Clin Oncol 29: 392-397, 2011."},{"key":"10","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/blood-2014-08-528398","volume":"125","author":"C Ng","year":"2015","unstructured":"10. Ng C, Motto DG, Di Paola J. Diagnostic approach to von Willebrand disease. Blood 125: 2029-2037, 2015.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Cattaneo M, Cerletti C, Harrison P, et al. Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC\/ISTH. J Thromb Haemost 2013.","DOI":"10.1111\/jth.12231"},{"key":"12","unstructured":"12. Baronciani L, Peyvandi F. How we make an accurate diagnosis of von Willebrand disease. Thrombosis Research Forthcoming."},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Araki M, Yang Y, Masubuchi N, et al. Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms. Blood 127: 1307-1316, 2016.","DOI":"10.1182\/blood-2015-09-671172"},{"key":"14","unstructured":"14. Hauschner H, Bokstad Horev M, Misgav M, et al. Platelets from Calreticulin mutated essential thrombocythemia patients are less reactive than JAK2V617F mutated platelets. Am J Hematol Forthcoming."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Liverani E, Rico MC, Tsygankov AY, Kilpatrick LE, Kunapuli SP. P2Y12 receptor modulates sepsis-induced inflammation. Arterioscler Thromb Vasc Biol 36: 961-971, 2016.","DOI":"10.1161\/ATVBAHA.116.307401"},{"key":"16","unstructured":"16. Bennett JS, Rao AK. Chapter 65. Inherited disorders of platelet function. In: Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 6th ed. Marder VJ, Aird WC, Bennett JS, Schulman S, White GC, Eds. Lippincott Williams & Wilkins, Philadelphia, PA, 2013."},{"key":"17","unstructured":"17. Rao AK, Bennett JS. Chapter 66. Acquired disorders of platelet function. In: Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 6th ed. Marder VJ, Aird WC, Bennett JS, Schulman S, White GC, Eds. Lippincott Williams & Wilkins, Philadelphia, PA, 2013."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Dovlatova N. Current status and future prospects for platelet function testing in the diagnosis of inherited bleeding disorders. Br J Haematol 170: 150-161, 2015.","DOI":"10.1111\/bjh.13405"},{"key":"19","unstructured":"19. Nurden AT, Nurden P. The gray platelet syndrome: clinical spectrum of the disease. Blood Rev 21: 21-36, 2007."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Stevenson WS, Morel-Kopp MC, Ward CM. Platelets are not all gray in GFI1B disease. Clin Genet 87: 299, 2015.","DOI":"10.1111\/cge.12424"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Gerrard JM, Phillips DR, Rao GH, et al. Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J Clin Invest 66: 102-109, 1980.","DOI":"10.1172\/JCI109823"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Nurden AT, Nurden P. Should any genetic defect affecting alpha-granules in platelets be classified as gray platelet syndrome? Am J Hematol 91: 714-718, 2016.","DOI":"10.1002\/ajh.24359"},{"key":"23","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood-2015-07-607952","volume":"127","author":"E Bianchi","year":"2016","unstructured":"23. Bianchi E, Norfo R, Pennucci V, Zini R, Manfredini R. Genomic landscape of megakaryopoiesis and platelet function defects. Blood 127: 1249-1259, 2016.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Israels SJ. Laboratory testing for platelet function disorders. Int J Lab Hematol 37 (Suppl): 18-24, 2015.","DOI":"10.1111\/ijlh.12346"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Gunay-Aygun M, Zivony-Elboum Y, Gumruk F, et al. Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p. Blood 116: 4990-5001, 2010.","DOI":"10.1182\/blood-2010-05-286534"},{"key":"26","first-page":"582","volume":"88","author":"CL Balduini","year":"2003","unstructured":"26. Balduini CL, Cattaneo M, Fabris F, et al. Inherited thrombocytopeneias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine. Haematologica 88: 582-592, 2003.","journal-title":"Haematologica","ISSN":"https:\/\/id.crossref.org\/issn\/0390-6078","issn-type":"print"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Guerrero JA, Bennett C, van der, Weyden L, et al. Gray platelet syndrome: proinflammatory megakaryocytes and alpha-granule loss cause myelofibrosis and confer metastasis resistance in mice. Blood 124: 3624-3635, 2014.","DOI":"10.1182\/blood-2014-04-566760"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Rottenstreich A, Kleinstern G, Krichevsky S, Varon D, Lavie D, Kalish Y. Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera. Eur J Intern Med 41: 49-54, 2017.","DOI":"10.1016\/j.ejim.2016.11.011"},{"key":"29","unstructured":"29. Kaufman RM, Djulbegovic B, Gernsheimer T, et al. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med 162: 205-213, 2015."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Briggs A, Gates JD, Kaufman RM, Calahan C, Gormley WB, Havens JM. Platelet dysfunction and platelet transfusion in traumatic brain injury. J Surg Res 193: 802-806, 2015.","DOI":"10.1016\/j.jss.2014.08.016"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Linnik YA, Salvatore LT, Lowrey CH, Ornstein DL. Severe acquired platelet dysfunction because of primary myelofibrosis with full functional and morphological recovery after allogeneic hematopoietic cell transplantation. Blood Coagul Fibrinolysis 30: 419-422, 2019.","DOI":"10.1097\/MBC.0000000000000850"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Cockbill SR, Burmester HBC, Heptinstall S. Pseudo grey platelet syndrome - grey platelets due to degranulation in blood collected into EDTA. Eur J Haematol 41: 326-333, 1988.","DOI":"10.1111\/j.1600-0609.1988.tb00205.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Mant MJ, Doery JC, Gauldie J, Sims H. Pseudothrombocytopenia due to platelet aggregation and degranulation in blood collected in EDTA. Scand J Haematol 15: 161-170, 1975.","DOI":"10.1111\/j.1600-0609.1975.tb01070.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/21\/59_4912-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T03:48:38Z","timestamp":1604720918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/21\/59_4912-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,1]]},"references-count":33,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4912-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,1]]}}}